Benztropine recalls
The FDA has published 3 recalls involving Benztropine since 2013. The latest was reported on 2 Jun 2021. Most were for particulate matter. Cardinal Health has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2013
Last 12 months0reported
Class I00% of total
Ongoing0latest 2 Jun 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 100%Class III 0 0%
Why benztropine is recalled
Companies
By year
All benztropine recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Benztropine Mesylate Tablets, USP in all pack sizes recalled | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS II | Benztropine Mesylate Injection, USP, 2 mg/mL(1 mg/ Single Dose Vial recalled | Nexus Pharmaceuticals | Particulate Matter | Nationwide |
| Drug | CLASS II | Benztropine Mesylate Injection, USP, 2 mg/ (1 mg/ Single Dose Vial recalledBenztropine Mesylate | Fresenius Kabi USA | Particulate Matter | Nationwide |
Should you stop taking Benztropine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.